 
SHARMA EAST INDIA HOSPITALS AND MEDICAL RESEARCH LTD. 
Regd. Office: Jaipur Hospital, Near SMS Stadium, Lal Kothi, Tonk Road, Jaipur -302015 (Raj.)  
Phone: 0141-2742557, 2742266                       CIN: L85110RJ1989PLC005206  
E-Mail: sharmaeastindia@gmail.com              Website: www .jaipurhospital.co.in 
 
 
November 14 2025 
To, 
Department of Corporate Service (DCS-CRD), 
BSE Limited 
Phiroze Jeejeebhoy Towers, 
Dalal Street, Fort, 
Mumbai – 400001 
 
Sub: Outcome of board meeting held on  November 14 2025 pursuant to Regulation 30 of 
the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 . 
 
Ref: SHARMA EAST INDIA HOSPIT ALS & MEDICAL RESEARCH LIMITED. Scrip Code: 
524548 
 
Dear Sir/Madam, 
 
This is to inform you that the Board of Directors of SHARMA EAST INDIA HOSPITALS AND 
MEDICAL RESEARCH LTD in their meeting held on today i.e., Friday, November 14 2025 at the 
registered office of the Company at 4.00 p.m. (IST) and concluded at 4.45 p.m. (IST) approved 
following:  
1. IND-AS compliant Standalone un-audited Financial Results for the quarter and half year 
ended on September 30  2025 pursuant to Regulation 33 of SEBI (Listing Obligations and 
Disclosure Requirement s) Regulations, 2015  along with limited review report.  
 
2. Statement of assets and liabilities for the half year ended September 30 202 5. 
 
3. Statement of cash flow for the half year ended September 30 2025.  
 
4. Shri. Rajeev Kumar (DIN: 07847472), has tendered his resignation as the Independent 
Director of the Company, with effect from close of business hours on November 14 2025, 
citing pre -occupation and other personal commitments. Consequently, he shall also 
cease to be a Chairman of the Audit Committee & Nomination and Remuneration 
Committee. 
 
The letter of resignation received from Shri. Rajeev Kumar (DIN: 07847472), is enclosed 
herewith. 
The information regarding the above -mentioned change in the Board composition in 
terms of Regulation 30 read with Schedule Ill - Para A(7B) of Part A of the Listing 
Regulations (as applicable) and SEBI Circular bearing Ref. No. CIR/CFD/CMD/4/2015 
dated 9th September 2015 is enclosed herewith – as per Annexure – I 
  
 
SHARMA EAST INDIA HOSPITALS AND MEDICAL RESEARCH LTD. 
Regd. Office: Jaipur Hospital, Near SMS Stadium, Lal Kothi, Tonk Road, Jaipur -302015 (Raj.)  
Phone: 0141-2742557, 2742266                       CIN: L85110RJ1989PLC005206  
E-Mail: sharmaeastindia@gmail.com              Website: www .jaipurhospital.co.in 
 
 
: 2 : 
 
5. Due to resignation of Shri. Rajeev Kumar (DIN: 07847472), as an Independent Director of 
the Company with effect from close of business hours on November 14 2025 , 
consequently, the Board of Directors at its meeting held today has approved 
reconstitution of Audit committee and Nomination and remuneration committee of the 
Board with immediate effect.  
 
The composition of the reconstituted committees is provided in Annexure – II 
 
Thanking you.   
Yours Faithfully 
For SHARMA EAST INDIA HOSPIT ALS & MEDICAL RESEARCH LIMITED 
  
 
____________________  
 Bhawana Sharma  
(Company Secretary  
And Compliance Officer)  
M. No. A61665  
Encl: as above.  
 
SHARMA EAST INDIA HOSPITALS AND MEDICAL RESEARCH LTD. 
Regd. Office: Jaipur Hospital, Near SMS Stadium, Lal Kothi, Tonk Road, Jaipur -302015 (Raj.)  
Phone: 0141-2742557, 2742266                       CIN: L85110RJ1989PLC005206  
E-Mail: sharmaeastindia@gmail.com              Website: www .jaipurhospital.co.in 
 
 
Annexure-I   
Brief Profile and details as per Regulation 30 of the SEBI (Listing Obligation s and 
Disclosure Requirements) Regulations, 2015.  
Shri. Rajeev Kumar (DIN: 07847472) 
Sr. 
No  
 
Particulars  
 
Remarks  
 
1. Reason for change viz. appointment, 
Resignation, removal, death or otherwise  
 
Resignation of Shri. Rajeev Kumar (DIN: 
07847472), as the Independent Director 
of the Company, with effect from close of 
business hours on November 14 2025. 
2. Date of appointment/cessation & 
term of appointment 
 
14-11-2025 
4. Brief Profile  
 
Not Applicable.  
5. Disclosure of relationship between directors 
(In case of appointment of a director)  
 
Not Applicable. 
 Additional Information in case of resignation of an Independent Director – Shri. Rajeev 
Kumar (DIN: 07847472). 
 
 
6. 
Letter of Resignation along with detailed 
reason for resignation.   
Enclosed herewith  
 
 
7. 
Names of listed entities in which the 
resigning director holds directorships, 
indicating the category of directorship 
and membership of board committees, if 
any. 
NIL  
 
8. 
The independent director shall, along 
with the detailed reasons, also provide 
confirmation that there are no other 
material reasons other than those 
provided. 
Shri. Rajeev Kumar (DIN: 07847472) has 
confirmed that there are no material 
reasons for his resignation other than 
those mentioned in his resignation 
letter 14th November 2025.  
 
For SHARMA EAST INDIA HOSPIT ALS & MEDICAL RESEARCH LIMITED 
  
 
 
____________________  
 Bhawana Sharma  
(Company Secretary  
And Compliance Officer)  
M. No. A61665  
 
SHARMA EAST INDIA HOSPITALS AND MEDICAL RESEARCH LTD. 
Regd. Office: Jaipur Hospital, Near SMS Stadium, Lal Kothi, Tonk Road, Jaipur -302015 (Raj.)  
Phone: 0141-2742557, 2742266                       CIN: L85110RJ1989PLC005206  
E-Mail: sharmaeastindia@gmail.com              Website: www .jaipurhospital.co.in 
 
 
 
Annexure – II 
COMPOSITION OF COMMITTEES OF BOARD OF DIRECTORS  
(effective from November 14 2025) 
A) AUDIT COMMITTEE: 
 
sr. 
No.  
Name of Members of 
Committee 
Nature of Directorship   Designation   
1. Srikant Vinayakrao Bulakh Independent Director Chairman  
2. Maya Sharma Non-Executive Director Member  
3. Radhika Sathe Non-Executive Director Member  
4. Dr Pushpendra Prasad Garg Independent Director Member  
5. Pawan Shorey Independent Director Member  
 
B) NOMINATION AND REMUNERATION COMMITTEE: 
 
 
sr. 
No.  
Name of Members of 
Committee 
Nature of Directorship   Designation   
1. Srikant Vinayakrao Bulakh Independent Director Chairman  
2. Maya Sharma Non-Executive Director Member  
3. Radhika Sathe Non-Executive Director Member  
4. Dr Pushpendra Prasad Garg Independent Director Member  
5. Pawan Shorey Independent Director Member  
 
 
 
  
 
  
  
SHARMA 
EAST 
INDIA 
HOSPITALS 
& 
MEDICAL 
RESEARCH 
LIMITED 
NEAR 
SMS 
STADIUM, 
LAL 
KOTHI, 
TONK 
ROAD 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
              
  
JAIPUR 
“s 
CIN: 
L85110RJ1989PLC005206 
STATEMENT 
OF 
UNAUDITED 
FINANCIAL 
RESULTS 
FOR 
THE 
QUARTER 
AND 
HALF 
YEAR 
ENDED 
30 
SEPTEMBER 
2025 
" (Rs. 
In 
lakhs, 
Except 
per 
share 
Data) 
“ 
Quarter 
Ended 
Year 
to 
date 
Ended 
Year 
Ended 
S. 
No. 
Particulars 
30.09.2025 
30.06.2025 
30.09.2024 
30.09.2025 
30.09.2024 
31.03.2025 
(Unaudited) 
(Unaudited) 
(Unaudited) 
(Unaudited) 
(Unaudited) 
(Audited) 
1|Income 
from 
Operations 
_ 
ee 
from 
Operations 
938.45 
947.37 
901.52 
1,885.82 
1,573.74 
2,987.20 
Taein 
come 
5.00 
4.00 
3.95 
9.00 
3.95 
31.39 
ose: 
evenue 
943.45 
951.37 
905.47 
1,894.82 
1,577.69 
3,018.59 
ses 
: 
ia 
ct 
mavens 
consumed 
176.42 
182.80 
160.43 
359.22 
235.32 
416.25 
° 
urchase 
: 
oar 
in 
_ 
212.79 
220.95 
160.13 
433.74 
323.10 
677.86 
be 
See 
in 
ae 
ories 
of 
stock 
in 
trade 
(35.00) 
- 
8.62 
(35.00) 
(13.74) 
(129.91) 
ae 
p 
ws 
oe 
ts 
expense 
129.44 
122.88 
113.51 
252.32 
210.71 
456.16 
e)| 
Finance 
cos 
10.17 
11.25 
24.99 
21.42 
42.02 
71.60 
(f) 
estan 
and 
amortisation 
expense 
42.91 
42.29 
44.49 
85.20 
79.94 
183.65 
o) 
tare 
of 
aan 
dens 
: 
241.32 
214.12 
194.26 
455.44 
343.75 
761.65 
ation 
and 
Surgery 
Expenses 
0.00 
2 
0.47 
- 
6.52 
6.52 
(i)| 
Other 
Expenses 
119.79 
114.10 
152.83 
233.89 
270.38 
433.53 
Total 
Expenses 
; 
897.84 
908.39 
859.73 
1,806.23 
1,498.00 
2,877.31 
: 
Sede 
exceptional 
items 
& 
tax 
(1-2) 
45.61 
42.98 
45.74 
88.59 
79.69 
141.28 
xceptional 
Items 
- 
- 
- 
- 
- 
- 
: 
ee 
before 
tax 
(3-4) 
45.61 
42.98 
45.74 
: 
88.59 
79.69 
141.28 
‘ax 
expense 
amin 
a 
trae 
16.43 
13.77 
11.89 
30.20 
20.72 
23.58 
axation 
for 
Earlier 
years 
= 
= = 
- 
- 
(0.06) 
—- 
i 
ee 
(2.59) 
- 
(5.19) 
- 
(6.67) 
‘o 
‘ax 
Expenses 
13.83 
11.18 
11.89 
25.01 
20.72 
16.85 
7|Profit/(Loss) 
~ 
the 
sae 
(5-6) 
31.78 
31.80 
33.85 
63.58 
58.97 
124.43 
8| 
Other 
Comprehensive 
Income 
Changes 
in 
fair 
value 
of 
investments 
in 
equity 
shares 
carried 
at 
fair 
value 
through 
OCI 
j 
(i) 
| Items 
that 
will 
not 
be 
reclassified 
to 
profit 
or 
loss 
- 
= 
- 
- 
- 
- 
(ii) 
|Income 
tax 
relating 
to 
items 
that 
will 
not 
be 
reclassified 
to 
profit 
or 
loss 
- 
% 
* 
- 
. 
7 
Other 
Comprehensive 
Income 
for 
the 
period 
z= 
- 
. 
- 
= 
: 
9| 
Total 
Comprehensive 
Income 
(7+8) 
31.78 
31.80 
33.85 
63.58 
58.97 
124.43 
10| 
Paid 
up 
equity 
share 
capital 
(face 
value 
of 
Rs. 
10/- 
each) 
328.38 
328.38 
328.38 
328.38 
328.38 
328.38 
11| 
Earnings 
per 
share 
Basic 
TS 
wr 
ca 
0.97 
0.97 
1.03 
1.94 
1.80 
3.79 
Diluted 
~ 
Ns 
0.97 
0.97 
1.03 
1.94 
1.80 
3.79 
. 
oN 
ss 
Bon 
Sry 
Se 
\ 
= = 
sf 
= 
a 
Z 
ey 
= 
pe 
KEN 
iS} 
  
 
Notes:- 
1. The above results have been reviewed by the Audit Committee and approved by 
the Board of Directors of the Company at its meeting held on 14th November, 
2025. The statutory Auditors have carried out Limited review of above Financial 
Results. 
2. The Company is not a Large Corporate as per the applicability criteria given 
under the SEBI circular SEBIHO/DDHS/CIR/P/2018/144 Dated “26 
November, 2018." 
3. The figures of the previous period / year have been re-grouped /re-arranged 
and / or recast wherever found necessary. 
4. These results have been prepared in accordance with Indian Accounting 
Standards (Ind AS’) specified under Section 133 of the Companies Act, 2013 
read with the relevant rules thereunder and pursuant to the requirements of 
the Regulation 33 of the SEBI (Listing Obligations and Disclosure 
Requirements) Regulations, 2015, (as amended), including relevant circulars 
issued by the SEBI from time to time. 
For SHARMA EAST INDIA HOSPITALS & 
MEDICAL RESEARC    
      
   naging Direct : 
IN 00432070 » Sor 
14.11.2025 
At Jaipur
  
SHARMA EAST INDIA HOSPITALS & MEDICAL RESEARCH LIMITED 
NEAR SMS STADIUM, TONK ROAD 
JAIPUR 
CIN: L85110RJ1989PLC005206 
STATEMENT OF UNAUDITED ASSETS & LIABILITIES AS AT SEPTEMBER 30, 2025 
(Rs. in lakhs) 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Particulars As at 30th As at 31st March 
September 2025 2025 
ASSETS 
Non-Current Assets 
(a) Property, Plant and Equipment 880.49 936.50 
(b)Capital work-in-progress - - 
(c ) Right of use assets - = 
(d) Intangible Assets - - 
(e) Financial Assets 
(i) Investments 204.77 204.77 
(ii) Others 157.64 146.64 
(f) Deferred Tax Assets (Net) - - 
(g) Other Non-Current Assets 31.86 31.86 
Total Non- Current Assets 1,274.76 1,319.77 
Current Assets 
(a) Inventories 351.89 316.89 
(b) Financial Assets 
(i) Trade Receivable 916.50 694.35 
(ii) Cash and Cash 45.50 44.82 
(iii) Bank balances other than - - 
(ii) above 
(iv) Others 12.39 9.14 
(b) Other Current Assets 546.00 422.49 
(c ) Current Tax Assets (Net) - - 
Total Current Assets 1,872.28 1,447.69 
Total Assets 3,147.04 2,767.46 
EQUITY AND LIABILITIES 
EQUITY 
(a) Equity Share capital 415.75 415.75 
(b) Other Equity 895.50 831.92 
Total Equity 1,311.25 1,247.67 
LIABILITIES 
Non-Current Liabilities 
(a) Financial] Liabilities 
(i) Borrowings 91.49 117.03 
(ii) Lease Liability - - 
(iii) Other Financial Liabilities - - 
(b) Deferred Tax Liability 16.10 21.29 
(c) Other Non Current Liabilities : - 
Total Non - current liabilities 107.59 138.32 
Current Liabilities 
(a) Financial Liabilities 
(i) Borrowings 427.31 108.83 
(ii) Trade Payables 
(A) total outstanding dues of - - 
micro enterprises and small 
enterprises; and 
(B) total outstanding dues of 695.91 627.98 
creditors other than micro 
enterprises and small 
enterprises. 
(iii) Lease Liability - = 
(iv) Other Financial Liabilities 563.52 562.56 
(b) Other Current Liabilities 11.26 58.52 
(c) Provisions 30.20 23.58 
Total Current liabilities 1,728.20 1,381.47 
Total Liabilities 1,835.79 1,519.79 
Total Equity and Liabilities A Ag 3,147.04 2,767.46 
  
\S AE MCD, 
   
  
  
SHARMA EAST INDIA HOSPITALS & MEDICAL RESEARCH LIMITED 
JAIPUR HOSPITAL, NEAR SMS STADIUM, LAL KOTHI, TONK ROAD 
JAIPUR, RAJASTHAN 
CIN: L85110RJ1989PLC005206 
STATEMENT OF CASH FLOWS FOR THE PERIOD ENDED 30TH SEPTEMBER 2025 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
        
Rs, In Lakhs 
For the period 
PARTICULARS ended September | Forthe ogee March 
30, 2025 ’ 
A. Cash Flow from Operating Activities 
Profit before tax 88.59 141.28 
Adjustments to reconcile profit before tax to net cash flows: 
Depreciation and impairment of property, plant and equipment 85.20 183.65 
(Gain)/Loss on disposal of property, plant and equipment ; (15.42) 
Interest income (9.00) (9.17) 
Finance costs 21.42 71,60 
Incremental Interest : - 
Movements in provisions 6.62 7.60 
Other adjustments to reconcile profit or loss ° 
Operating Profit before working capital changes 192.83 379,54 
Working Capital Changes: 
(Increase)/Decrease in other assets and liabilities 
(3.25) (32.47) 
Increase/(Decrease) in non current financial assets (11.00) 683.19 
(Increase)/Decrease in trade receivables and other receivables (262.14) (395.88) 
(Increase)/Decrease in other current financial assets : ie 
(Increase)/Decrease in other current assets (123.51) (96.60) 
(Increase)/Decrease in inventories (35.00) (248.70) 
Increase/(Decrease) in other current financial liabilities 0.96 300.90 
Increase/(Decrease) in other current liabilities (47.26) (25.28) 
Increase/(Decrease)in trade payables 67.92 128.09 
Cash Generated from Operations (220,45) 692.79 
Income tax paid (30.20) (23.52) 
Net Cash from Operating Activities (A) (250.65) 669.27 
B. Cash Flow from Investing Activities 
Proceeds from sale of property, plant and equipment = 41.50 
Purchase of property, plant and equipment (including Capital Work in 
Progress) (29.19) (376.49) 
Interest received 9.00 9.17 
Net Cash used in Investing Activities(B) (20.19) (325.82) 
C. Cash Flow from Financing Activities 
Proceeds from / (Repayment of) Short Term Borrowings 318.48 (278.57) 
Proceeds from / (Repayment of) Long Term Borrowings (25.54) 0.23 
Interest Paid (21.42) (71.60) 
Net cash used in Financing Activities (C) 271.52 (349.94) 
Net increase/(Decrease) in cash and cash equivalents(A+B+C) 0.68 (6.49) 
Cash and cash equivalents at the beginning of the year 44.82 51.31 
Cash and cash equivalents at the end of the year 45.50 ~ 44,82 
Cash and Cash Equivalent includes:- | 
Cash in hand 10.78 7.44 
Balance with Banks in current accounts 34,72 37.38 
Total 45.50 44,82 
  
   
 
GOPAL SHARMA & CO. 
Chartered Accountants 
 
 
G-2, Plot No. – 2A, Golden Palace, Krishna Marg, C-scheme, Jaipur-302001, Rajasthan  
Phone: 0141-2360700, Mail: gopalsharmaco@gmail.com 
Independent Auditor’s Limited Review Report on Unaudited Half-Yearly 
Standalone Financial Results of the Company, Sharma East India Hospitals & 
Medical Research Limited pursuant to the Regulation 33 of the SEBI (Listing 
Obligations and Disclosure Requirements) Regulations, 2015 (as amended) 
 
To, 
The Board of Directors 
Sharma East India Hospitals & Medical Research Ltd  
 
1. We have reviewed the accompanying Statement of Un-audited Standalone 
Financial Results of Sharma East India Hospitals & Medical Research Limited 
(the “company”) for the quarter and half year ended on 30th September 2025 
being submitted by the company pursuant to the requirements of the Regulation 
33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 
2015, (as amended), including relevant circulars issued by the SEBI from time 
to time.  
 
2. This Statement, which is the responsibility of the Company’s Management and 
approved by the Company’s Board of Directors, has been prepared in 
accordance with the recognition and measurement principles laid down in 
Indian Accounting Standard 34, (Ind AS 34) “Interim Financial Reporting” 
prescribed under Section 133 of the Companies Act, 2013 as amended, read 
with relevant rules issued there under and other accounting principles generally 
accepted in India and in compliance with Regulation 33 of the SEBI (Listing 
Obligations and Disclosure Requirements) Regulations, 2015, (as amended). 
Our responsibility is to express a conclusion on the Statement based on our 
review. 
 
3. We conducted our review of the Statement in accordance with the Standard on 
Review Engagements (SRE) 2410, Review of Interim Financial Information 
performed by the Independent Auditor of the Entity, issued by the Institute of 
Chartered Accountants of India. This standard requires that we plan and 
perform the review to obtain moderate assurance as to whether the Statement is 
free of material misstatement. A review of interim financial information 
consists of making inquiries, primarily of persons responsible for financial and 
accounting matters, and applying analytical and other review procedures. A 
review is substantially less in scope than an audit conducted in accordance with 
the Standards on Auditing specified under Section 143(10) of the Companies 
Act 2013, and consequently, does not enable us to obtain assurance that we 
would become aware of all significant matters that might be identified in an 
 
GOPAL SHARMA & CO. 
Chartered Accountants 
 
 
G-2, Plot No. – 2A, Golden Palace, Krishna Marg, C-scheme, Jaipur-302001, Rajasthan  
Phone: 0141-2360700, Mail: gopalsharmaco@gmail.com 
audit and hence review provides less assurance than an audit. We have not 
performed an audit and accordingly, we do not express an audit opinion. 
 
4. Based on our review conducted as above, nothing has come to our attention 
that causes us to believe that the accompanying statement, prepared in 
accordance with the recognition and measurement principles laid down in the 
aforesaid Indian Accounting Standards (‘Ind AS') specified under Section 133 
of the Companies Act, 2013 as amended, read with relevant rules issued 
thereunder and other recognized accounting practices and policies has not 
disclosed the information required to be disclosed in terms of the Listing 
Regulations, including the manner in which it is to be disclosed, or that it 
contains any material misstatement. 
 
 
FOR GOPAL SHARMA & CO.  
CHARTERED ACCOUNTANTS 
 
 
 
 
(CA GAURAV BADLANI) 
Jaipur                                                                                                PARTNER 
November 14, 2025  
                                                                                              Membership No. 476189 
                                                                                     Firm Registration No. 002803C 
 
 
                                                                                    UDIN: 25476189BMZWOP9840 
GAURAV 
BADLANI
Digitally signed by 
GAURAV BADLANI 
Date: 2025.11.14 
17:00:05 +05'30'
